Chugai Pharmaceutical

Ladies and gentlemen, thank you very much for attending the conference on FY 2020 for December financial results for Chugai Pharmaceutical. I am acting as a master of ceremony for today. My name is Miyata from IR department. We are holding this session in a hybrid manner. The agenda for today's presentation are shown on the presentation material page 3 on the screen in the venue. However, for those who are participating through Zoom webinar, you will be able to hear simultaneous translation. Please select the language of your choice by clicking the button at the bottom of your screen. For those who wish to listen to Japanese, please select Japanese. English, please select English. After selecting your preferred language, please click on mute original audio. At the beginning of each session, we are going to pose for a while for those to take a photo of the screen. We are going to take questions at the very end of the presentation. We allocate about 30 minutes for Q&A session.

Your audio is muted during the presentation session.

Now, Okuda will take you to the summary of year 2024 and outlook into 2025. We are going to pause for a while before the presentation of Okuda, so for those who wish to take screen capture, please do so.